Brand profile · Pharmaceutical Manufacturing

New Zealand Pharmaceuticals Limited

New Zealand Pharmaceuticals runs a Pharmaceutical Manufacturing operation from Palmerston North, Manawatu. Ownership is privately held; it publishes at icepharma.com. It holds one address on record, all in New Zealand. The record counts 64 people. Tagged biotechnology manufacturing, pharmaceutical ingredients and pharmaceutical intermediates. The latest round on record is Grant at US$200.1K. The record links nine similar brands, most of them in Pharmaceutical Manufacturing.

Profile live Privately Held Founded 1971 1 office country US$ 200.1K Grant

Key facts

Counted staff
64
self-reported 51–200 band
Founded
1971
55 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
1
Grant · Feb 2014 · US$ 200.1K
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Description

New Zealand Pharmaceuticals (NZP) and Dextra Laboratories proudly joined ICE Pharma following a successful merger which was completed in August 2020.

NZP develops and manufactures biopharmaceutical products specialising in high purity bile acids, blood group products, complex carbohydrates and other pharmaceutical intermediates and APIs.

Established in 1971 to extract and purify biochemicals from by-products of the New Zealand meat processing industry, NZP has evolved over its ~50 year history into a diversified developer and manufacturer of high value pharmaceutical ingredients with a global raw material procurement and end-product distribution network.

Today, NZP is a valued supplier to leading global pharmaceutical manufacturers worldwide.

Specialties

All 7 specialties
  • biotechnology manufacturing
  • pharmaceutical ingredients
  • pharmaceutical intermediates
  • microbiological media
  • fermentation ingredients
  • dietary supplements
  • cosmetic ingredients

Locations

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary NZ. Codes: NZ.1 countryprimary NZNZ
Show as table · Offices in 1 country
Offices in 1 country
Countries1
Primary countryNZ

All codes: NZ

Addresses

  • NZ68 Weld Street, RD2; Linton; Palmerston North, Manawatu 4472Primary

Grid intelligence Members

Funding

Last round · 6 February 2014US$ 200.1KGrant · investor: Callaghan Innovation
Rounds1
Round typeGrant · non-equity funding
Amount (USD)200,100
Stage rank1
Investors named1
Since last round11 yr 11 mo

Funding

1 funding roundFunding timeline. Latest round 6 Feb 2014: Grant, US$ 200.1K.19712026GrantUS$ 200.1K1 round
Show as table · 1 funding round
1 funding round
Rounds1
Axis1971 to 2026
Grant · 6 Feb 2014US$ 200.1K

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

How many people work at New Zealand Pharmaceuticals Limited?

The record holds 64 counted staff profiles at January 2026, inside the self-reported 51–200 band.

Where does New Zealand Pharmaceuticals Limited have offices?

One address on record, New Zealand only. Primary: 68 Weld Street, RD2, Linton, Palmerston North, Manawatu 4472.

Has New Zealand Pharmaceuticals Limited raised funding?

One round. Latest 6 February 2014: grant, US$200,100, investor Callaghan Innovation.

What does New Zealand Pharmaceuticals Limited list as its specialties?

Seven tags on the brand's own list, among them biotechnology manufacturing, pharmaceutical ingredients and pharmaceutical intermediates.

Which companies are listed alongside New Zealand Pharmaceuticals Limited?

22 profiles list New Zealand Pharmaceuticals Limited as a peer — 95th percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. Douglas Pharmaceuticals and AFT Pharmaceuticals list it back.

What is New Zealand Pharmaceuticals Limited's website?